Helen W. Davey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helen W. Davey has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- David J. Waxman
Department of Biology and Bioinformatics Program, Boston University , Boston, MA 02215
3 shared publications Richard J. Wilkins
AgResearch, Ruakura Research Centre, and 2Department of Biological Sciences, University of Waikato, Hamilton, New Zealand; and 3Division of Cell and Molecular Biology, Department of Biology, Boston University, Boston
2 shared publications- Russell Grant Snell
University of Auckland
2 shared publications Soo-Hee Park
From ‡AgResearch, Ruakura Research Centre, Private Bag 3123, Hamilton, New Zealand, the ‖Division of Cell and Molecular Biology, Department of Biology, Boston University, Boston, Massachusetts 02215, and the **Department of Anatomy and Structural Biology, School of Medical Sciences, University of Otago, Dunedin, New Zealand
2 shared publications- David R. Grattan
Centre for Neuroendocrinology, University of Otago, Dunedin, New Zealand
1 shared publication - Douglas J. Hilton
Walter and Eliza Hall Institute of Medical Research
1 shared publication
Latest Publications
- Open Access
- 1 December 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (50) , 35331-35336
STAT5b-deficient Mice Are Growth Hormone Pulse-resistant
- 1 December 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (50) , 35331-35336
Open AccessSTAT5b-deficient Mice Are Growth Hormone Pulse-resistant
- 1 December 1999
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 158 (1-2) , 111-116
STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver
- 1 December 1999
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 158 (1-2) , 111-116
STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver
- 1 October 1999
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 65 (4) , 959-965
STAT5 Signaling in Sexually Dimorphic Gene Expression and Growth Patterns
- 1 October 1999
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 65 (4) , 959-965
STAT5 Signaling in Sexually Dimorphic Gene Expression and Growth Patterns
- 8 July 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (14) , 7239-7244
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
The signal transducer and activator of transcription, STAT5b, has been implicated in signal transduction pathways for a number of cytokines and growth factors, including growth hormone (GH). Pulsatile but not continuous GH exposure activates liver STAT5b by tyrosine phosphorylation, leading to dimerization, nuclear translocation, and transcriptional activation of the STAT, which is proposed to play a key role in regulating the sexual dimorphism of liver gene expression induced by pulsatile plasma GH. We have evaluated the importance of STAT5b for the physiological effects of GH pulses using a mouse gene knockout model. STAT5b gene disruption led to a major loss of multiple, sexually differentiated responses associated with the sexually dimorphic pattern of pituitary GH secretion. Male-characteristic body growth rates and male-specific liver gene expression were decreased to wild-type female levels in STAT5b −/− males, while female-predominant liver gene products were increased to a level intermediate between wild-type male and female levels. Although these responses are similar to those observed in GH-deficient Little mice, STAT5b −/− mice are not GH-deficient, suggesting that they may be GH pulse-resistant. Indeed, the dwarfism, elevated plasma GH, low plasma insulin-like growth factor I, and development of obesity seen in STAT5b −/− mice are all characteristics of Laron-type dwarfism, a human GH-resistance disease generally associated with a defective GH receptor. The requirement of STAT5b to maintain sexual dimorphism of body growth rates and liver gene expression suggests that STAT5b may be the major, if not the sole, STAT protein that mediates the sexually dimorphic effects of GH pulses in liver and perhaps other target tissues. STAT5b thus has unique physiological functions for which, surprisingly, the highly homologous STAT5a is unable to substitute.
- 8 July 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (14) , 7239-7244
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
The signal transducer and activator of transcription, STAT5b, has been implicated in signal transduction pathways for a number of cytokines and growth factors, including growth hormone (GH). Pulsatile but not continuous GH exposure activates liver STAT5b by tyrosine phosphorylation, leading to dimerization, nuclear translocation, and transcriptional activation of the STAT, which is proposed to play a key role in regulating the sexual dimorphism of liver gene expression induced by pulsatile plasma GH. We have evaluated the importance of STAT5b for the physiological effects of GH pulses using a mouse gene knockout model. STAT5b gene disruption led to a major loss of multiple, sexually differentiated responses associated with the sexually dimorphic pattern of pituitary GH secretion. Male-characteristic body growth rates and male-specific liver gene expression were decreased to wild-type female levels in STAT5b −/− males, while female-predominant liver gene products were increased to a level intermediate between wild-type male and female levels. Although these responses are similar to those observed in GH-deficient Little mice, STAT5b −/− mice are not GH-deficient, suggesting that they may be GH pulse-resistant. Indeed, the dwarfism, elevated plasma GH, low plasma insulin-like growth factor I, and development of obesity seen in STAT5b −/− mice are all characteristics of Laron-type dwarfism, a human GH-resistance disease generally associated with a defective GH receptor. The requirement of STAT5b to maintain sexual dimorphism of body growth rates and liver gene expression suggests that STAT5b may be the major, if not the sole, STAT protein that mediates the sexually dimorphic effects of GH pulses in liver and perhaps other target tissues. STAT5b thus has unique physiological functions for which, surprisingly, the highly homologous STAT5a is unable to substitute.